
Opinion|Videos|September 25, 2024 (Updated: September 25, 2024)
Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics
Experts in the management of mood disorders comment on the evolving management of major depressive disorder, emphasizing findings from the STAR*D trial, updated treatment guidelines, and the role of precision medicine and the shift toward personalized, rapid-acting treatments to improve patient outcomes.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
2
Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder
5







